Abstract: A process for preparing compounds of formula (I), by nitrosating compounds of formula (II), compounds of formula (I) having pharmaceutical activity.

Abstract: The present invention provides a system and method of mediating cell traffic between an asynchronous transmission mode (ATM) network and an adjacent network, each cell in said cell traffic having a set of transmission parameters related to the ATM network and a respective ATM connection for the cell.

Abstract: A system and method of translating a set of transmission parameters related to a first transmission protocol from said first transmission protocol to a second transmission protocol for a data element being sent on a connection from a first communication network utilizing the first transmission protocol to a second communication network utilizing the second transmission protocol is provided. The method includes mapping a first parameter from the set of transmission parameters to a class of service value for the connection and mapping the class of service value and a second parameter from the set of transmission parameters to another parameter for the second transmission protocol.

Abstract: A system and method of reassembling packets from traffic flows in a network element is provided. Each of the packets has at least one data part. The method includes the steps (1) queuing each of the data parts of the packets of traffic flows in a single reassembly queue in a sorted order, the data parts of each of the packets being continuously grouped without data parts of another packet being interleaved therein and (2) reassembling the data parts of each of the packets queued in the single reassembly queue.

Abstract: The invention provides a system and method of controlling timing of release of traffic for a communication switch. The traffic originates from at least one source, is directed to a common ingress point of the switch and is directed to a common egress point in the switch. The egress point has a maximum egress transmission rate. The traffic has at least one datastream. Each datastream has a requested transmission rate. The method comprises, for each datastream, establishing a maximum cell release rate such that a sum of each of the maximum cell release rate does not exceed the maximum egress transmission rate and utilizing the maximum cell release rate to govern release of local traffic in the datastream from the ingress point.

Abstract: 1

Abstract: A process for the preparation of a 4-aryl-3-oxymethyl-piperidine of structure (1) 1

Abstract: A process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein R.sub.1 represents (a) in which r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1; R.sub.2 is a group OR.sub.4, where R.sub.4 is C.sub.1-4 alkyl, C.sub.2-4 alkenyl or C.sub.2-4 alkynyl or a group OCOR.sub.5 where R.sub.5 is hydrogen or R.sub.4 ; and R.sub.3 is CN; said process comprising reacting a compound of formula (II) wherein R.sub.1 ' is R.sub.1 or a group convertible thereto, and R.sub.3 ' is an electron withdrawing group, with a source of nitrous acid, and thereafter converting the resulting .dbd.NOH group to .dbd.NR.sub.2 wherein R.sub.2 is as defined in formula (I), converting R.sub.1 ' and R.sub.3 ' when other than R.sub.1 and R.sub.3 to R.sub.1 and R.sub.3, and thereafter optionally forming a pharmaceutically acceptable salt.

Abstract: A process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sub.1 represents ##STR2## in which r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1;R.sub.2 is a group OR.sub.4, where R.sub.4 is C.sub.1-4 alkyl, C.sub.2-4 alkenyl or C.sub.2-4 alkynyl or a group OCOR.sub.5 where R.sub.5 is hydrogen or R.sub.4 ; andR.sub.3 is CN;said process comprising reacting a compound of formula (II): ##STR3## wherein R.sub.1 ' is R.sub.1 or a group convertible thereto, and R.sub.3 ' is an electron withdrawing group, with a source of nitrous acid, and thereafter converting the resulting .dbd.NOH group to .dbd.NR.sub.2 wherein R.sub.2 is as defined in formula (I), converting R.sub.1 ' and R.sub.3 ' when other than R.sub.1 and R.sub.3 to R.sub.1 and R.sub.3, and thereafter optionally forming a pharmaceutically acceptable salt.

Abstract: The invention relates to a carrying case with a theft prevention clamp. It is especially designed for laptop computers left in public places, but may also be used to prevent other items from being stolen. The clamp is designed to removably fasten the carrying case to a table, but may also be used on shelves or other objects with similarly shaped surfaces. The clamp has a flexible portion and a rigid portion. The carrying case has an upper portion and a lower portion, which are pivotally connected. There is a lock for securing the upper portion to the lower portion when they are in a closed position. A keyhole switch activates a battery-powered electric motor to extend the clamp when a key is inserted, if the key is turned clockwise, or to retract the clamp, if the key is turned counterclockwise. Once the clamp is extended, it and the lower portion of the carrying case can be inserted around a table or other object with similar surfaces.

Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof (I) wherein R.sub.1 represents (a), R.sub.2 is a group OCH.sub.3, and R.sub.3 is cyano, for use in the treatment and/or prophylaxis of dementia in mammals.